Evidence map›Paper›PMID 39494439›Full record

ArticleFujita medical journal2024

Current management of

Shogo Hanai, Masashi Yokose, Yukinori Harada, Yohei Doi, Taro Shimizu

Abstract read
In one paragraph

Article in Fujita medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shogo HanaiDepartments of Microbiology and Infectious Diseases, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Masashi YokoseDepartment of Diagnostic and Generalist Medicine, Dokkyo Medical University, School of Medicine, Shimotsuga, Tochigi, Japan.
Yukinori HaradaDepartment of Diagnostic and Generalist Medicine, Dokkyo Medical University, School of Medicine, Shimotsuga, Tochigi, Japan.
Yohei DoiDepartments of Microbiology and Infectious Diseases, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Taro ShimizuDepartment of Diagnostic and Generalist Medicine, Dokkyo Medical University, School of Medicine, Shimotsuga, Tochigi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Consultation with infectious disease specialists is associated with reduced patient mortality in the care of patients with Methods: We conducted a retrospective cohort study at Dokkyo Medical University Hospital in Japan. Patients eligible for inclusion in the study were ≥20 years of age with ≥1 positive blood culture for Results: A total of 109 patients with SAB were included in the analysis. Follow-up blood cultures were collected in 91 patients and negative results were documented in 88 patients. Follow-up blood culture collection was performed within 4 days of the initial blood culture collection in 49 patients. Echocardiography was performed appropriately in 40 patients. Appropriate antibiotic therapy was administered in 36 patients. Conclusions: Quality-of-care indicators were more commonly implemented in patients with SAB who received general internal medicine consultation than in those who did not.

Indexed as

EchocardiographyGeneral internal medicineManagementStaphylococcus aureus bacteremia

Identifiers

PMID39494439
PMCPMC11528325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.